SCHEMBL20148166

SCHEMBL20148166

CCOc1ccc(/C(Cl)=N\O)c(F)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CPS1 P31327 2/20 0.43
MAOB P27338 4/20 0.42
KDM4E B2RXH2 1/20 0.42
MAOA P21397 1/20 0.42
NQO1 P15559 1/20 0.39
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
USP2 O75604 1/20 0.37
PKM P14618 1/20 0.36
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
KAT6A Q92794 1/20 0.36
PARP10 Q53GL7 2/20 0.36
PARP15 Q460N3 1/20 0.36
PARP14 Q460N5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18302342 1.00 CPS1 (0.43) CPS1MAOBKDM4EMAOANQO1
SCHEMBL18302344 1.00 CPS1 (0.43) CPS1MAOBKDM4EMAOANQO1
SCHEMBL18489241 0.82 CPS1 (0.50) CPS1NPC1MAPTRAB9A
SCHEMBL18502969 0.82 CPS1 (0.50) CPS1NPC1MAPTRAB9A
SCHEMBL18489238 0.82 CPS1 (0.50) CPS1NPC1MAPTRAB9A
SCHEMBL20136407 0.78 ALDH1A1 (0.46) CPS1MAOBMAOAFFAR4KAT6A
SCHEMBL20148162 0.78 ALDH1A1 (0.46) CPS1MAOBMAOAFFAR4KAT6A
SCHEMBL20136409 0.78 ALDH1A1 (0.46) CPS1MAOBMAOAFFAR4KAT6A
SCHEMBL18302297 0.76 PDE2A (0.40) MAPTFFAR1FFAR4
SCHEMBL20148147 0.76 PDE2A (0.40) MAPTFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors AXOVANT SCIENCES GMBH (CH) 2019-08-06 US disclosed
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370370-B2 Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors CHRNA7, CHRNA5, CHRNA2 CPS1 3297/4885MAOB 301/4885KDM4E 2804/4885
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 CPS1 3238/4885MAOB 204/4885KDM4E 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.